GS-441524 is an antiviral nucleoside analogue widely referenced in veterinary FIP management programs. Oral tablet formulations have become increasingly popular among veterinarians and cat caregivers because they provide a convenient alternative to injectable administration during long-term treatment cycles.
This product contains 20mg GS-441524 per tablet and is designed for oral use in cats requiring antiviral support related to feline infectious peritonitis (FIP). The lower tablet strength allows flexible dosage adjustment according to body weight, making it suitable for kittens, smaller cats, or gradual dosage management programs.
Feline infectious peritonitis is caused by a mutation of feline coronavirus. Once the virus spreads through the body, it may affect multiple organs and trigger severe inflammatory reactions. Depending on the type of FIP involved, symptoms may include abdominal fluid accumulation, organ inflammation, eye complications, or neurological abnormalities.
The tablet formulation is manufactured under controlled production conditions and packaged for stable room-temperature storage.
| Item | Details |
|---|---|
| Product Name | GS-441524 Tablets |
| Active Ingredient | GS-441524 |
| Strength | 20mg per tablet |
| Dosage Form | Oral Tablets |
| Main Function | Cat FIP Support |
| Shelf Life | 12 Months |
| Storage Condition | Room Temperature |
| Country of Manufacture | China |
Each package includes production batch information and expiration labeling for traceability.
Feline infectious peritonitis (FIP) is considered a serious viral disease in cats. It develops when feline coronavirus mutates and gains the ability to spread systemically through immune cells.
Veterinary professionals commonly divide FIP into several forms:
Different clinical forms may require different antiviral dosage strategies and treatment durations.
The 20mg dosage allows easier adjustment for smaller cats and individualized treatment planning.
Tablet administration may reduce stress caused by repeated injections during long treatment periods.
Oral formulations are commonly considered during maintenance stages or daily antiviral management programs.
The tablets are produced under controlled standards to maintain consistent quality and stable active ingredient concentration.
The product can be stored at room temperature in a dry environment, making transportation and handling more convenient.
GS-441524 tablet dosage is generally determined according to body weight and the clinical type of FIP.
| FIP Type | Treatment Consideration |
|---|---|
| Wet FIP | Standard antiviral support |
| Dry FIP | Moderate dosage adjustment may be needed |
| Ocular / Neurological FIP | Higher support protocols may be considered |
| Relapse Cases | Ongoing dosage monitoring recommended |
Treatment plans should be adjusted according to veterinary guidance and the cat’s condition.
GS-441524 20mg tablets are commonly supplied to:
The oral format may simplify daily administration for caregivers managing extended antiviral treatment schedules.
To maintain tablet stability:
Under recommended conditions, the product remains stable for up to one year from the manufacturing date.
